Evidence map›Paper›PMID 28729939›Full record

ArticleBrain and behavior2017

Feature selective temporal prediction of Alzheimer's disease progression using hippocampus surface morphometry.

Sinchai Tsao, Niharika Gajawelli, Jiayu Zhou, Jie Shi, Jieping Ye, Yalin Wang, Natasha Leporé

Abstract read
In one paragraph

Article in Brain and behavior, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Diverse Applications of Artificial Intelligence in Neuroradiology.Neuroimaging clinics of North America · 2020
    Review
  6. Patch-Based Surface Morphometry Feature Selection with Federated Group Lasso Regression.Proceedings of SPIE--the International Society for Optical Engineering · 2020
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sinchai TsaoCIBORG Children's Hospital Los Angeles and University of Southern California Los Angeles CA USA.ORCID 0000-0003-4009-178X
Niharika GajawelliCIBORG Children's Hospital Los Angeles and University of Southern California Los Angeles CA USA.
Jiayu ZhouDepartment of Computer Science and Engineering Michigan State University East Lansing MI USA.
Jie ShiSchool of Computing, Informatics and Decision Systems Engineering Arizona State University Phoenix AZ USA.
Jieping YeDepartment of Computational Medicine and Bioinformatics & Department of Electrical Engineering and Computer Science University of Michigan Ann Arbor MI USA.
Yalin WangSchool of Computing, Informatics and Decision Systems Engineering Arizona State University Phoenix AZ USA.
Natasha LeporéCIBORG Children's Hospital Los Angeles and University of Southern California Los Angeles CA USA.

Funding

Project 1U19AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI MICHAEL W WEINER · 2016 to 2026
$226.7M
Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
Multi-Source Sparse Learning to Identify MCI and Predict DeclineRF1AG051710 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI THOMPSON, PAUL M, WANG, YALIN · 2016 to 2016
$2.8M
Empowering Diffusion MRI Measures by Integrating White and Grey Matter MorphologyR21AG049216 · NIA · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI WANG, YALIN · 2015 to 2016
$381k
NIA NIH HHS R21 AG049216NIA NIH HHS RF1 AG051710NIA NIH HHS U01 AG024904NIA NIH HHS U19 AG024904
6 · The paper itself

Abstract

introductionPrediction of Alzheimer's disease (AD) progression based on baseline measures allows us to understand disease progression and has implications in decisions concerning treatment strategy. To this end, we combine a predictive multi-task machine learning method (cFSGL) with a novel MR-based multivariate morphometric surface map of the hippocampus (mTBM) to predict future cognitive scores of patients.

methodsPrevious work has shown that a multi-task learning framework that performs prediction of all future time points simultaneously (cFSGL) can be used to encode both sparsity as well as temporal smoothness. The authors showed that this method is able to predict cognitive outcomes of ADNI subjects using FreeSurfer-based baseline MRI features, MMSE score demographic information and ApoE status. Whilst volumetric information may hold generalized information on brain status, we hypothesized that hippocampus specific information may be more useful in predictive modeling of AD. To this end, we applied a multivariate tensor-based parametric surface analysis method (mTBM) to extract features from the hippocampal surfaces.

resultsWe combined mTBM features with traditional surface features such as middle axis distance, the Jacobian determinant as well as 2 of the Jacobian principal eigenvalues to yield 7 normalized hippocampal surface maps of 300 points each. By combining these 7 × 300 = 2100 features together with the previous ~350 features, we illustrate how this type of sparsifying method can be applied to an entire surface map of the hippocampus that yields a feature space that is 2 orders of magnitude larger than what was previously attempted.

conclusionsBy combining the power of the cFSGL multi-task machine learning framework with the addition of AD sensitive mTBM feature maps of the hippocampus surface, we are able to improve the predictive performance of ADAS cognitive scores 6, 12, 24, 36 and 48 months from baseline.

Indexed as

HippocampusMachine LearningMagnetic Resonance ImagingAgedAged, 80 and overAlzheimer DiseaseCognitionDisease ProgressionFemaleHumansMaleMiddle AgedNeuroimagingPredictive Value of TestsPrognosisTemporal LobeAlzheimer's Diseasedementiahippocampusmachine learningmulti‐task learningtensor‐based morphometry

Identifiers

PMID28729939
PMCPMC5516607

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.